Check out companies making headlines in expanded trading: Tesla – Stocks were slightly lower in expanded trading after quarter results missed analysts’ top-line and bottom-line estimates. The electric vehicle company won 27 cents per share with revenue of $19.34 billion, adjusted to 27 cents per share, while analysts voted by LSEG were looking for 39 cents per share and revenue of $21.1 billion. Enphase Energy – The energy technology company sank more than 12% after its first quarter results missed Wall Street estimates. Enphase reported an adjusted earnings of 68 cents per share against revenues of $356 million, while Analyst surveyed LSEG’s forecast earnings of 70 cents per share and revenue of $361 million. The low-end of Enphase’s second quarter revenue forecast also did not reach analyst estimates. Intuitive Surgical – Biotechnology stock has lost almost 6%. The company warned that the 2025 non-GAAP gross profit margin ranged from 65% to 66.5% of revenue, down from 69.1% in 2024, reflecting the estimated effect from tariffs. Outlook overshadowed the beats on the top and bottom line of the first quarter. SAP – Software inventory was captured nearly 7% shortly after the first quarter revenue beat. The company won an adjusted $1.44 per share, with analysts voted by LSEG looking for $1.32 per share. OKLO – The nuclear technology company has retreated nearly 11% following news that Openai CEO and Oklo Chairman Sam Altman has resigned from the startup. The move is widely expected to increase the flexibility to pursue partnerships with hyperschools, including openness. Packaging Corporation of America – Manufacturing stocks slipped over 5% after the company’s second quarter revenue outlook missed analyst estimates. PKG is forecasting earnings of $2.41 per share this quarter, but analysts voting on fact set were looking for $2.63 per share. Bristol Myers Squibb – The biopharmaceutical giant fell nearly 6%. The company said that when used as a supplementary treatment for adults with schizophrenia, the Phase 3 trial of the drug Covenfee could not show statistically significant results. Manhattan Associates – According to Factset, the supply chain software provider has raised 6% at the top of the top consensus street estimate of $1.03, with a top consensus street estimate of $1.19 per share. Non-GAAP operational margins and software licenses, maintenance and services revenue all exceeded what analysts expected per StreetAccount. – CNBC’s Darla Mercado and Scott Schnipper contributed the report. Get tickets for Pro Live Join us on the New York Stock Exchange! An uncertain market? Earn Edge with CNBC Pro Live, the first exclusive event on the historic New York Stock Exchange. Access to expert insights is paramount in today’s dynamic financial situation. As a CNBC Pro subscriber, we encourage you to take part in the first exclusive, in-person CNBC Pro live event held at the iconic NYSE on Thursday, June 12th. Join ProSCarter Worte, an interactive pro clinic led by Dan Niles and Dan Ives, along with a special edition of Pro Talks with Tom Lee. You will also get the opportunity to network with CNBC experts, talent and other pro subscribers during exciting cocktail hours on the legendary trading floor. Tickets are limited!
